Innovative technology for analyzing individual cells in cancer
Advanced Single Cell Technology Innovation Core
This study is exploring new ways to look closely at individual cells in tumors to better understand how they work together and contribute to cancer, which could help create more effective treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11171868 on NIH RePORTER |
What this research studies
This research focuses on developing advanced technologies to analyze individual cells within tumors, aiming to understand the different cell states that contribute to cancer progression. By utilizing cutting-edge methods like single-cell RNA sequencing and CRISPR techniques, the project seeks to provide insights into how cells interact and function within the tumor microenvironment. Patients may benefit from the enhanced understanding of cancer biology, which could lead to more targeted and effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who are interested in contributing to advancements in cancer treatment.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in personalized cancer therapies by identifying specific cell behaviors and interactions that drive tumor growth.
How similar studies have performed: Other research has shown success with similar single-cell analysis approaches, indicating a promising avenue for understanding complex diseases like cancer.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Sims, Peter Alan — Columbia University Health Sciences
- Study coordinator: Sims, Peter Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.